Dr. Schorry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
Ml 4006
Cincinnati, OH 45229Phone+1 513-636-4760Fax+1 513-636-7297- Is this information wrong?
Education & Training
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1984 - 1985- Cincinnati Childrens Hospital Medical CenterInternship, Transitional Year, 1982 - 1983
University of Michigan Medical SchoolClass of 1982
Certifications & Licensure
OH State Medical License 1985 - 2026- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Clinical Trials
- A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 Start of enrollment: 2009 Jul 01
- Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas Start of enrollment: 2010 Jul 10
- Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Start of enrollment: 2013 May 15
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsConsensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance...Amy L Xu, Krishna V Suresh, Jaime A Gomez, John B Emans, A Noelle Larson, Patrick J Cahill, Lindsay M Andras, Klane K White, Daniel J Miller, Joshua S Murphy, Mari L G...> ;Journal of Pediatric Orthopedics. 2023 Aug 1
- Motor Function and Physiology in Youth With Neurofibromatosis Type 1.Alexander C Doherty, David A Huddleston, Paul S Horn, Nancy Ratner, Brittany N Simpson, Elizabeth K Schorry, Lindsey Aschbacher-Smith, Carlos E Prada, Donald L Gilbert> ;Pediatric Neurology. 2023 Jun 1
- 24 citationsMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag, Ashley Cannon, Eva Dombi, Jason Fangusaro, Bruce D Gelb, Darren Hargrave,...> ;Neuro-Oncology. 2022 Nov 2
- Join now to see all
Journal Articles
- Expanding the Clinical Phenotype of Individuals with a 3-Bp in-Frame Deletion of the NF1 Gene (c.2970_2972del): An Update of Genotype–Phenotype CorrelationRachel K Hachen, Elizabeth K Schorry, Arthur S Aylsworth, Katherine A Rauen, Ashraf Syed, Daryl A Scott, Lois J Starr, Donald G Basel, Lynne M Bird, Leah W Burke, Mari..., Nature
- Copb2 Is Essential for Embryogenesis and Hypomorphic Mutations Cause Human MicrocephalyElizabeth Schorry, Kristen Sund, Cynthia A Prows, Human Molecular Genetics
Hospital Affiliations
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio- Highland District HospitalHillsboro, Ohio
University of Cincinnati Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
